Pluristem Therapeutics Inc (PSTI)

[zzaatt]

The difference between the two of us is that i still have high hopes for a decent ROI.

[ref to "Eich"] Actually, you have MANY other differences, all to YOUR advantage!

As far as "Allo/FDA" I have no idea what he (or anyone else) owns, what I do appreciate is:

1. He provides more DD than the rest of us put together.
2. He shares his findings
3. He's enthusiastic about PSTI's chances of success.

You might think he's unrealistically enthusiastic, but at least he's on the side of the people who need success more than anyone else, the patients. Short term predictions are risky (that's one reason I don't make any), but in the long run I do agree with him:

1. there will be a contract from US Gov. for PLX-R18
2. PLX-R18 will be used in many other conditions where reconstituting blood components is essential (radiation therapy)
3. PLX-PAD will give us a successful P3 for CLI
4. there are many other indications where Pluristem's MSCs will be applicable
5. they have the patent protection to commercialize these products exclusively
etc., etc.

Of course, I could be wrong (but I think it's a good bet).